Gordts PL - Search Results

1

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering.

Ramms B, Patel S, Sun X, Pessentheiner AR, Ducasa GM, Mullick AE, Lee RG, Crooke RM, Tsimikas S, Witztum JL, Gordts PL. Ramms B, et al. Among authors: gordts pl. JCI Insight. 2022 Jul 8;7(13):e158414. doi: 10.1172/jci.insight.158414. JCI Insight. 2022. PMID: 35653195 Free PMC article.

2

Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling.

Gordts PLSM, Foley EM, Lawrence R, Sinha R, Lameda-Diaz C, Deng L, Nock R, Glass CK, Erbilgin A, Lusis AJ, Witztum JL, Esko JD. Gordts PLSM, et al. Cell Metab. 2014 Nov 4;20(5):813-826. doi: 10.1016/j.cmet.2014.09.016. Epub 2014 Nov 4. Cell Metab. 2014. PMID: 25440058 Free PMC article.

3

Dietary nitrate struggles in atherosclerosis.

Ramms B, Gordts PL. Ramms B, et al. Among authors: gordts pl. Atherosclerosis. 2016 Feb;245:71-3. doi: 10.1016/j.atherosclerosis.2015.12.007. Epub 2015 Dec 11. Atherosclerosis. 2016. PMID: 26708286 No abstract available.

4

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.

Gordts PL, Nock R, Son NH, Ramms B, Lew I, Gonzales JC, Thacker BE, Basu D, Lee RG, Mullick AE, Graham MJ, Goldberg IJ, Crooke RM, Witztum JL, Esko JD. Gordts PL, et al. J Clin Invest. 2016 Aug 1;126(8):2855-66. doi: 10.1172/JCI86610. Epub 2016 Jul 11. J Clin Invest. 2016. PMID: 27400128 Free PMC article.

5

Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.

Moriarty PM, Varvel SA, Gordts PL, McConnell JP, Tsimikas S. Moriarty PM, et al. Among authors: gordts pl. Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):580-588. doi: 10.1161/ATVBAHA.116.308704. Epub 2017 Jan 5. Arterioscler Thromb Vasc Biol. 2017. PMID: 28062489 Free PMC article.

6

Novel Lipoprotein(a) Catabolism Pathway via Apolipoprotein(a) Recycling: Adding the Plasminogen Receptor PlgR_KT to the List.

Yeang C, Gordts PL, Tsimikas S. Yeang C, et al. Among authors: gordts pl. Circ Res. 2017 Mar 31;120(7):1050-1052. doi: 10.1161/CIRCRESAHA.117.310700. Circ Res. 2017. PMID: 28360338 Free PMC article. No abstract available.

7

ANGPTL3 targeting: The power of versatile lipid-lowering.

Pessentheiner AR, Ramms B, Gordts PLSM. Pessentheiner AR, et al. Atherosclerosis. 2018 Jan;268:185-187. doi: 10.1016/j.atherosclerosis.2017.10.002. Epub 2017 Oct 6. Atherosclerosis. 2018. PMID: 29111225 Free PMC article. No abstract available.

8

Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism.

Ramms B, Gordts PLSM. Ramms B, et al. Curr Opin Lipidol. 2018 Jun;29(3):171-179. doi: 10.1097/MOL.0000000000000502. Curr Opin Lipidol. 2018. PMID: 29547399 Review.

9

Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants.

Tirronen A, Vuorio T, Kettunen S, Hokkanen K, Ramms B, Niskanen H, Laakso H, Kaikkonen MU, Jauhiainen M, Gordts PLSM, Ylä-Herttuala S. Tirronen A, et al. Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2327-2337. doi: 10.1161/ATVBAHA.118.311549. Arterioscler Thromb Vasc Biol. 2018. PMID: 30354205

10

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.

Ramms B, Patel S, Nora C, Pessentheiner AR, Chang MW, Green CR, Golden GJ, Secrest P, Krauss RM, Metallo CM, Benner C, Alexander VJ, Witztum JL, Tsimikas S, Esko JD, Gordts PLSM. Ramms B, et al. J Lipid Res. 2019 Aug;60(8):1379-1395. doi: 10.1194/jlr.M093740. Epub 2019 May 14. J Lipid Res. 2019. PMID: 31092690 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page